Pay in 4 interest-free payments of $5.31 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
In a pivotal trial of 142 adult patients with progressing desmoid tumors not amenable to surgery, Ogsiveo elicited clinically meaningful and statistically significant improvement in the primary endpoint of progression-free survival compared to placebo
Kim is very educated and easy to talk to
Note recent vomiting, diarrhea, illness, vigorous exercise, or major dietary changes because these may affect interpretation
Mployer AI throughout Catalyst The Mployer AI panel is now available on every Catalyst search grid: Employer, Commercial P&C, Broker, Carrier, Company, PEO, and Retirement
US$ 26.21
US$ 27.39
US$ 25.49
US$ 22.60
